Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions
- PMID: 19616729
- DOI: 10.1016/j.annemergmed.2009.01.026
Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions
Comment on
-
Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.Ann Emerg Med. 2009 Mar;53(3):329-38. doi: 10.1016/j.annemergmed.2008.04.025. Epub 2008 Jun 5. Ann Emerg Med. 2009. PMID: 18534716
Similar articles
-
Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.Ann Pharmacother. 2009 Jul;43(7):1258-65. doi: 10.1345/aph.1L610. Epub 2009 Jul 7. Ann Pharmacother. 2009. PMID: 19584385 Review.
-
Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension.Pharmacotherapy. 2010 May;30(5):515-28. doi: 10.1592/phco.30.5.515. Pharmacotherapy. 2010. PMID: 20412001 Review.
-
Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.Expert Rev Cardiovasc Ther. 2009 May;7(5):465-72. doi: 10.1586/erc.09.1. Expert Rev Cardiovasc Ther. 2009. PMID: 19419254
-
Clevidipine (Cleviprex) for IV treatment of severe hypertension.Med Lett Drugs Ther. 2008 Sep 22;50(1295):73-4. Med Lett Drugs Ther. 2008. PMID: 18800023 No abstract available.
-
Clevidipine for the treatment of severe hypertension in adults.Clin Ther. 2010 Jan;32(1):11-23. doi: 10.1016/j.clinthera.2010.01.025. Clin Ther. 2010. PMID: 20171407 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical